Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mustang Bio (MBIO) has provided an update.
Mustang Bio, Inc. has entered into an agreement with H.C. Wainwright & Co. to potentially sell shares of its common stock at market prices. The company can sell shares up to $5.6 million under this new arrangement, subject to SEC regulations. Additionally, Mustang Bio terminated its previous sales agreement, effective June 5, 2024, which had allowed for the sale of up to $100 million in common stock. This strategic shift in its stock offering approach allows for sales at times and amounts of the company’s choosing, with a 3% commission to the managing firm.
See more data about MBIO stock on TipRanks’ Stock Analysis page.